Hedge Fund - Rhenman & Partners Asset Management
Jazz Pharmaceuticals Plc (JAZZ)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $15,431,845 | 1.77% | 124,300 | $130.46 |
| 2 | 2024 - Q4 (2024-12-31) | $17,918,325 | 1.84% | 145,500 | $117.86 |
| 3 | 2024 - Q3 (2024-09-30) | $10,361,130 | 0.84% | 93,000 | $109.58 |
| 4 | 2024 - Q2 (2024-06-30) | $12,167,220 | 1.16% | 114,000 | $109.94 |
| 5 | 2024 - Q1 (2024-03-31) | $17,669,106 | 1.67% | 146,729 | $122.49 |
| 6 | 2023 - Q4 (2023-12-31) | $15,206,982 | 1.51% | 123,634 | $124.79 |
| 7 | 2023 - Q3 (2023-09-30) | $18,591,985 | 2% | 143,634 | $133.25 |
| 8 | 2023 - Q2 (2023-06-30) | $17,975,650 | 1.89% | 145,000 | $134.55 |
| 9 | 2023 - Q1 (2023-03-31) | $21,738,000 | 2.38% | 150,000 | $147.92 |
| 10 | 2022 - Q4 (2022-12-31) | $20,391,680 | 2.12% | 128,000 | $146.56 |
| 11 | 2022 - Q3 (2022-09-30) | $18,908,000 | 1.97% | 131,500 | $152.05 |
| 12 | 2022 - Q2 (2022-06-30) | $24,962,000 | 2.83% | 160,000 | $153.94 |
| 13 | 2022 - Q1 (2022-03-31) | $28,328,000 | 2.79% | 181,976 | $145.12 |
| 14 | 2021 - Q4 (2021-12-31) | $37,195,000 | 2.47% | 290,000 | $131.42 |
| 15 | 2021 - Q3 (2021-09-30) | $36,459,000 | 2.55% | 280,000 | $151.09 |
| 16 | 2021 - Q2 (2021-06-30) | $39,081,000 | 2.65% | 220,000 | $173.22 |
| 17 | 2021 - Q1 (2021-03-31) | $41,093,000 | 2.86% | 250,000 | $164.55 |
| 18 | 2020 - Q4 (2020-12-31) | $36,311,000 | 2.96% | 220,000 | $148.94 |
| 19 | 2020 - Q3 (2020-09-30) | $24,240,000 | 2.15% | 170,000 | $123.97 |
| 20 | 2020 - Q2 (2020-06-30) | $15,120,000 | 1.63% | 137,032 | $110.58 |
| 21 | 2020 - Q1 (2020-03-31) | $11,969,000 | 1.67% | 120,000 | $129.29 |
| 22 | 2019 - Q4 (2019-12-31) | $15,048,000 | 1.64% | 100,805 | $136.08 |
| 23 | 2019 - Q3 (2019-09-30) | $19,221,000 | 2.4% | 150,000 | $134.05 |
| 24 | 2019 - Q2 (2019-06-30) | $26,683,000 | 2.93% | 187,171 | $134.39 |
| 25 | 2018 - Q4 (2018-12-31) | $20,555,000 | 2.34% | 165,818 | $148.35 |
| 26 | 2018 - Q3 (2018-09-30) | $21,239,000 | 2.12% | 126,322 | $171.98 |
| 27 | 2018 - Q2 (2018-06-30) | $22,130,000 | 2.26% | 128,436 | $163.46 |
| 28 | 2018 - Q1 (2018-03-31) | $22,412,000 | 2.76% | 148,436 | $146.69 |
| 29 | 2017 - Q4 (2017-12-31) | $17,967,000 | 2.42% | 133,436 | $138.70 |
| 30 | 2017 - Q3 (2017-09-30) | $12,431,000 | 1.58% | 85,000 | $151.23 |
| 31 | 2017 - Q2 (2017-06-30) | $13,221,000 | 1.89% | 85,020 | $152.92 |
| 32 | 2017 - Q1 (2017-03-31) | $8,754,000 | 1.38% | 60,320 | $130.25 |
| 33 | 2016 - Q4 (2016-12-31) | $5,552,000 | 1.06% | 50,920 | $111.38 |
| 34 | 2016 - Q3 (2016-09-30) | $7,288,800,000 | 1.15% | 60,000 | $134.79 |
| 35 | 2016 - Q2 (2016-06-30) | $9,892,000 | 1.75% | 70,000 | $147.42 |
| 36 | 2016 - Q1 (2016-03-31) | $3,917,000 | 0.77% | 30,000 | $124.48 |
| 37 | 2015 - Q4 (2015-12-31) | $5,904,000 | 0.89% | 42,000 | $138.57 |
The displayed share prices are average quarterly stock market prices.